149 related articles for article (PubMed ID: 5467824)
21. [Treatment of diabetes mellitus with tolazamide].
Nava M; Mendoza M
Prensa Med Mex; 1967; 32(1):56-8. PubMed ID: 5633826
[No Abstract] [Full Text] [Related]
22. Glibenclamide in the management of diabetes mellitus. I.
Devlin JG; Manning K; Harty J
J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
[No Abstract] [Full Text] [Related]
23. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
Pereira VG; Wajchenberg BL; Shnaider J
Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
[No Abstract] [Full Text] [Related]
24. [Effect of tolazamide on serum cholesterol].
López Amor E; Lozano Castañeda O; Domenque L
Rev Invest Clin; 1966; 18(2):229-37. PubMed ID: 5973929
[No Abstract] [Full Text] [Related]
25. A new oral hypoglycemic agent. Tolazamide (Tolinase).
JAMA; 1966 Oct; 198(3):308-9. PubMed ID: 5952933
[No Abstract] [Full Text] [Related]
26. Tolazamide in the treatment of diabetes mellitus.
Baird IM; Evans JH; Hirst J; Longson D
Practitioner; 1967 Feb; 198(184):264-7. PubMed ID: 6038982
[No Abstract] [Full Text] [Related]
27. [On the clinical use of biguanides].
Haese E
Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
[No Abstract] [Full Text] [Related]
28. A clinical trial of glybenclamide (HB-419): a new oral hypoglycemic agent.
Choudhry AS; Gomez E; McKendry JB
Appl Ther; 1970 May; 12(5):28-9. PubMed ID: 4912481
[No Abstract] [Full Text] [Related]
29. [Oral differential therapy of diabetes mellitus].
Mehnert H
Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
[No Abstract] [Full Text] [Related]
30. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
Marocco F; Patrito G
Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
[No Abstract] [Full Text] [Related]
32. Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes.
Turtle JR
Br Med J; 1970 Sep; 3(5723):606-10. PubMed ID: 5470087
[TBL] [Abstract][Full Text] [Related]
33. Insulin and oral hypoglycemic agents.
Price MJ
Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
[No Abstract] [Full Text] [Related]
34. [Oral diabetes therapy. Possibilities and limits].
Bachmann W
Internist (Berl); 1981 Apr; 22(4):204-10. PubMed ID: 7014509
[No Abstract] [Full Text] [Related]
35. [Comparative investigations with Redul in sulfonylurea therapy].
Stratmann FW
Med Welt; 1967 Nov; 46():2794-5. PubMed ID: 5606416
[No Abstract] [Full Text] [Related]
36. [Treatment with a new antidiabetic: glybenclamide].
Madsen SN; Persson I
Ugeskr Laeger; 1970 Jan; 132(4):143-7. PubMed ID: 5442953
[No Abstract] [Full Text] [Related]
37. [Treatment of diabetes mellitus with the E.R. 105 oral preparation].
Domingo Gutiérrez AJ
Rev Iber Endocrinol; 1969; 16(96):449-63. PubMed ID: 4906090
[No Abstract] [Full Text] [Related]
38. [Oral antidiabetic monotherapy and combination treatment with glybenclamide (HB 419) and biguanides of insulin receiving diabetics of the adult type].
Knick B; Wendt O; Konder ML; Netter P
Med Klin; 1970 Jan; 65(3):109-12. PubMed ID: 5519048
[No Abstract] [Full Text] [Related]
39. Lichenoid drug reactions to chlorpropamide and tolazamide.
Barnett JH; Barnett SM
Cutis; 1984 Dec; 34(6):542-4. PubMed ID: 6240374
[TBL] [Abstract][Full Text] [Related]
40. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
